0001654954-23-014413.txt : 20231115 0001654954-23-014413.hdr.sgml : 20231115 20231115115305 ACCESSION NUMBER: 0001654954-23-014413 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GSK plc CENTRAL INDEX KEY: 0001131399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15170 FILM NUMBER: 231409635 BUSINESS ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS BUSINESS PHONE: 011442080475000 MAIL ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS FORMER COMPANY: FORMER CONFORMED NAME: GSK PLC DATE OF NAME CHANGE: 20220516 FORMER COMPANY: FORMER CONFORMED NAME: GLAXOSMITHKLINE PLC DATE OF NAME CHANGE: 20010105 6-K 1 a4518t.htm BLOCK LISTING INTERIM REVIEW a4518t
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of November 2023
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Date: 15 November 2023
 
Name of applicant:
 
GSK plc
 
Name of scheme:
 
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
 
Period of return:
 
  From:
 
1 May 2023  
 
To:
 
31 October 2023
 
Balance of unallotted securities under scheme(s) from previous return:
 
271,307
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
271,307
 
 
 
Name of applicant:
 
GSK plc
 
Name of scheme:
 
GlaxoSmithKline plc Share Save Plan 2012
 
Period of return:
 
  From:
 
1 May 2023 
 
To:
 
31 October 2023
 
Balance of unallotted securities under scheme(s) from previous return:
 
558,829
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
52,231
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
506,598
 
 
 
Name of applicant:
 
GSK plc
 
Name of scheme:
 
GlaxoSmithKline plc Share Save Plan 2022
 
Period of return:
 
  From:
 
1 May 2023 
 
To:
 
31 October 2023
 
Balance of unallotted securities under scheme(s) from previous return:
 
999,954
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
845
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
999,109
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: November 15, 2023
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc